Related Experiment Video
Updated: Jul 10, 2026
05:16
Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Duchenne muscular dystrophy: issues in expanding newborn screening
Alex R Kemper1, Melissa A Wake
1Program on Pediatric Health Services Research, Department of Pediatrics, Duke University, Durham, North Carolina 27705, USA. alex.kemper@duke.edu
Current Opinion in Pediatrics
|November 21, 2007
Summary
Newborn screening for Duchenne muscular dystrophy shows variable accuracy and causes parental anxiety. Insufficient data exist on benefits, costs, and long-term impacts to recommend routine screening.
Area of Science:
- Medical screening
- Genetics
- Pediatrics
Background:
- Newborn screening aims to detect genetic disorders early.
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting muscle function.
- Evaluating screening programs requires understanding potential risks and benefits.
Purpose of the Study:
- To assess the risks and benefits of newborn screening for Duchenne muscular dystrophy.
- To identify knowledge gaps in current evidence regarding DMD screening.
- To inform recommendations for future newborn screening policies.
Main Methods:
- Review of existing literature on Duchenne muscular dystrophy newborn screening.
- Analysis of reported positive predictive values for creatine kinase screening.
- Evaluation of data on parental anxiety and reproductive planning.
Main Results:
- Positive predictive values for DMD screening vary significantly.
- Screening can cause parental anxiety due to early detection and false positives.
- Limited data exist on the impact of early diagnosis on children and cost-effectiveness.
Conclusions:
- Current data are insufficient to recommend routine newborn screening for Duchenne muscular dystrophy.
- Further research is needed to evaluate the risks, benefits, and costs of DMD screening.
- Understanding evidence gaps is crucial for developing informed screening guidelines.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:28Disorders of the Skeletal Muscle
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...